Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maike Reith
Observed name:
Reith, Maike
Institutions:
German Cancer Research Center,
Heidelberg University,
University Medical Centre Mannheim
Observed institutions:
University of Freiburg,
German Cancer Research Center,
Heidelberg University,
University Medical Center Freiburg,
University Medical Centre Mannheim
OpenAlex ID:
A5073768008
Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab
2015
·
Christoffer Gebhardt
, Alexandra Sevko
, et al.
·
Clinical Cancer Research
·
390
Tumor microenvironment-derived S100A8/A9 is a novel prognostic biomarker for advanced melanoma patients and during immunotherapy with anti-PD-1 antibodies
2019
·
Nikolaus B. Wagner
, Benjamin Weide
, et al.
·
Journal for ImmunoTherapy of Cancer
·
109
PDF
Inhibition of human B-cell development into plasmablasts by histone deacetylase inhibitor valproic acid
2013
·
Anne-Kathrin Kienzler
, Marta Rizzi
, et al.
·
Journal of Allergy and Clinical Immunology
·
43
PDF
Diminished levels of the soluble form of RAGE are related to poor survival in malignant melanoma
2015
·
Nikolaus B. Wagner
, Benjamin Weide
, et al.
·
International Journal of Cancer
·
42
PDF
Melanoma-Derived iPCCs Show Differential Tumorigenicity and Therapy Response
2017
·
Mathias Bernhardt
, Daniel Novak
, et al.
·
Stem Cell Reports
·
39
PDF
Directed Dedifferentiation Using Partial Reprogramming Induces Invasive Phenotype in Melanoma Cells
2016
·
Nathalie Knappe
, Daniel Novak
, et al.
·
Stem Cells
·
39
PDF
RAGE ligand S100A8/A9 as a novel prognostic biomarker for high-risk melanoma patients.
2014
·
Christoffer Gebhardt
, Nikolaus B. Wagner
, et al.
·
Journal of Clinical Oncology
·
2
Data from Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab
2023
·
Christoffer Gebhardt
, Alexandra Sevko
, et al.
Supplementary Figure Legends from Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab
2023
·
Christoffer Gebhardt
, Alexandra Sevko
, et al.
Supplementary Table 1. from Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab
2023
·
Christoffer Gebhardt
, Alexandra Sevko
, et al.
Supplementary Fig. 2 from Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab
2023
·
Christoffer Gebhardt
, Alexandra Sevko
, et al.
Supplementary Fig. 1 from Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab
2023
·
Christoffer Gebhardt
, Alexandra Sevko
, et al.
Abstract 805: Subcellular distribution of RAGE affects its functions in melanoma growth and progression
2015
·
Maike Reith
, Wolf-Henning Gebhardt
, et al.
·
Cancer Research
Role of RAGE in melanoma development, growth, and progression
2015
·
Reith, Maike
·
heiDOK (Heidelberg University)
PDF
Novel Predictive Biomarkers in Melanoma Treatment with Ipilimumab
2015
·
Christoffer Gebhardt
, Alexandra Sevko
, et al.
Show more works
View as search
Works count:
17
Citation count:
664
H-index:
6
I10-index:
6
Year
Topic
Type